NF-κB pathway controls mitochondrial dynamics
نویسندگان
چکیده
منابع مشابه
MicroRNAs Modulate the Dynamics of the NF-κB Signaling Pathway
BACKGROUND NF-κB, a major transcription factor involved in mammalian inflammatory signaling, is primarily involved in regulation of response to inflammatory cytokines and pathogens. Its levels are tightly regulated since uncontrolled inflammatory response can cause serious diseases. Mathematical models have been useful in revealing the underlying mechanisms, the dynamics, and other aspects of r...
متن کاملECM controls flow-induced NF-κB
he spindle checkpoint blocks exit from mitosis until all kinetochores are bound by spindle micro-tubules. At that point, Cdc20 is released by the checkpoint proteins and activates the anaphase promoting complex (APC), a ubiquitin ligase, to initiate anaphase. On page 61, Casaletto et al. identify Xnf7 as the first APC regulator known to bind the core APC components, rather than Cdc20. On page 4...
متن کاملP133: Targeting NF-Κb Signaling Pathway as Potential Therapeutic with Curcumin in Treatment of Multiple Sclerosis
Curcumin is active component of turmeric and isolated from the rhizome of turmeric, a phenolic natural product. One of inflammatory disease is multiple sclerosis, a multifocal chronic autoimmune inflammatory disease of the CNS, which is also known as a perivascular demyelinating disease. Studies have been shown that neuro-inflammation can have both harmful and beneficial effects on the neuronal...
متن کاملCharting the NF-κB Pathway Interactome Map
Inflammation is part of a complex physiological response to harmful stimuli and pathogenic stress. The five components of the Nuclear Factor κB (NF-κB) family are prominent mediators of inflammation, acting as key transcriptional regulators of hundreds of genes. Several signaling pathways activated by diverse stimuli converge on NF-κB activation, resulting in a regulatory system characterized b...
متن کاملColorectal cancer and NF-κB signaling pathway
Colorectal cancer (CRC) is the second leading cause of cancer death. Progress has been made in the development of chemotherapy for advanced CRC. Targeted therapies against VEGF or EGFR are now commonly used. However, many cases show that tolerance develops to such treatments; therefore, new strategies are required to replace or complement current therapies. Nuclear factor-κB (NF-κB) transcripti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cell Death & Differentiation
سال: 2015
ISSN: 1350-9047,1476-5403
DOI: 10.1038/cdd.2015.42